Epidermal growth factor receptor (EGFR) belongs to the RTK protein family and is dysregulated in the majority of malignant tumors, such as lung cancer, colorectal carcinoma, breast and head/neck cancers [19,20]. Here, EGFR is linked to lung carcinoma.